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We have identified a novel homozygous nonsense mutation
(W516X) in the kidney-type electrogenic sodium bicarbonate
cotransporter 1 (NBC1) in a patient with isolated proximal
renal tubular acidosis (pRTA). To specifically address the
pathogenesis of this mutation, we created NBC1 W516X
knock-in mice to match the patient’s abnormalities.
The expression of NBC1 mRNA and protein in the kidneys
of NBC1W516X/W516X mice were virtually absent, indicating
that nonsense-mediated mRNA decay (NMD) is involved in
the defective transcription and translation of this mutation.
These mice not only recapitulated the phenotypes of this
patient with growth retardation, pRTA, and ocular
abnormalities, but also showed anemia, volume depletion,
prerenal azotemia, and several organ abnormalities,
culminating in dehydration and renal failure with early
lethality before weaning. In isolated renal proximal tubules,
both NBC1 activity and the rate of bicarbonate absorption
were markedly reduced. Unexpectedly, there was no
compensatory increase in mRNA of distal acid/base
transporters. Sodium bicarbonate but not saline
administration to these mutant mice markedly prolonged
their survival, decreased their protein catabolism and
attenuated organ abnormalities. The prolonged survival time
uncovered the development of corneal opacities due to
corneal edema. Thus, NBC1W516X/W516X mice with pRTA
represent an animal model for metabolic acidosis and may be
useful for testing therapeutic inhibition of NMD in vivo.
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The kidneys are the most important regulators of acid-base
homeostasis. First, filtered HCO3
 should be reabsorbed,
largely via proximal hydrogen (Hþ ) secretion to prevent
HCO3
 loss. This process is initiated by the electroneutral
Naþ /Hþ exchanger 3 (NHE3) in the luminal membrane
and the kidney-type electrogenic Naþ /HCO3
 cotransporter
(NBC1) in the basolateral membrane.1,2 In a process known
as ‘regeneration,’ the kidney forms new HCO3
 to replace the
HCO3
 that was utilized in buffering of the daily net Hþ
load.3 Regeneration occurs in the distal tubules primarily via
the vacuolar-type Hþ -ATPases in the luminal membrane
and anion exchanger 1 in the basolateral membrane to
add new HCO3
 to the body.4 Defects in the reclamation and
regeneration of HCO3
 cause the so-called proximal and
distal renal tubular acidosis (RTA), respectively.5
Defects in NHE3 or NBC1 can theoretically reduce the
reabsorption of filtered HCO3
 and cause proximal RTA
(pRTA). Mutations in the NHE3 gene have not been
identified in patients with pRTA to date. On the other hand,
mutations in the NBC1 gene (SLC4A4) have been reported in
patients with autosomal recessive isolated pRTA.6–10 Because
NBC1 is also expressed in the ocular tissues and brain,
patients with inactivating mutations in NBC1 have ocular
abnormalities (glaucoma, band keratopathy, and cataracts) as
well as calcifications of the basal ganglia.11,12 The current
therapy for these patients includes sufficient fluid intake,
potassium, NaHCO3, active vitamin D, and phosphate
supplementation to reduce the complications of metabolic
acidosis, electrolyte imbalances, and osteomalacia.13
To date, 11 NBC1 mutations have been identified
in patients with isolated pRTA (Figure 1).6–10,14–16 Functional
expression study of mutants in Xenopus oocytes and
mammalian cells have demonstrated that NBC1 activity is
significantly reduced.9,10,14,15 Recently, we have identified a
novel nonsense NBC1 mutation (W516X) from a Chinese
girl with isolated pRTA with ocular abnormalities and
calcifications in bilateral basal ganglion. A suitable animal
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model is needed to specifically address the pathogenesis
of this nonsense NBC1 mutation. Unlike knockout mice
models, knock-in mice models accurately represent human
genetic diseases and can be used to address more specific
questions regarding pathophysiology and provide new
insights into rescue therapies.17,18 Therefore, in this study,
we generated NBC1 W516X knock-in mice to represent
human disease caused by NBC1 W516X mutation.
RESULTS
Index case
A 7-year-old Chinese girl from non-consanguineous parents
was consulted for the evaluation of hypokalemia and
persistent hyperchloremic metabolic acidosis. She was
delivered after a normal pregnancy but had a developmental
delay and failure to strive. She was found to have bilateral
basal ganglion calcification when she was hospitalized
because of muscle weakness and shortness of breath resulting
from severe metabolic acidosis (pH 7.16, HCO3
– 10mmol/l)
and profound hypokalemia (Kþ 1.8mEq/l) at the age of 4.
Despite regular NaHCO3 (9.75 g/day) and KCl (2.07 g/day)
supplementation, she developed progressive blurred vision
because of corneal calcification.
On physical examination, her height (102 cm) and weight
(13.8 kg) were less than the third percentile. Bilateral band
keratopathy, cataracts, and glaucoma were observed in the
eye examination. Laboratory investigation revealed hypo-
kalemia (Kþ 2.2mEq/l) with renal Kþ wasting and hyper-
chloremic metabolic acidosis (pH 7.26, Cl 116mEq/l, and
HCO3
 12mmol/l). Her serum creatinine was 0.6mg/dl,
urine pH was 5.0, urine net charge (Naþ /Kþ -Cl) was
positive (16mEq/l). Her serum amylase concentration was
normal. A higher fractional excretion of HCO3
 (26%
4normal 15%) during an intravenous NaHCO3 (2–3mEq/h)
loading test confirmed the diagnosis of pRTA. Isolated
permanent pRTA with ocular abnormality was then estab-
lished. Her plasma Kþ and HCO3
 concentrations remained
around 3.0 and 14mmol/l, respectively, with regular oral
potassium citrate (50mmol/day) and active vitamin D3
(0.25 mg/day) supplementation.
PCR amplification and direct sequencing of the SLC4A4
gene revealed a novel, homozygous, and a guanine to adenine
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Figure 1 |Pedigree of this family and electrogenic Naþ /HCO3
 cotransporter (NBC1) mutations. (a) Male and female are indicated
by squares and circles, respectively. Filled symbols represent the affected individuals. (b) Genomic DNA sequencing of SLC4A4 and
restriction analysis with AlwI endonuclease show a homozygous W516X mutation in the proband (P), heterozygous mutation in her father
(F), and no mutation in her mother (M). (c) Proposed topography of the NBC1 and the identified mutations. W516X is denoted with
% (star) and located at transmembrane domain 4 (TM 4).
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substitution at nucleotide 1548 (TGG to TGA) in exon 11
(Figure 1a and b). This resulted in a nonsense mutation from
tryptophan (W) at codon 516 (W516X) (Figure 1c). W516X
mutation was undetected in 100 healthy subjects. This W516X
was transmitted from the patient’s father but not from her
mother. Both parents did not have pRTA. Haplotype analysis
verified that father and mother were biological parents. Because
her mother did not carry a heterozygous W516X mutation,
de novo mutation on another allele may account for homo-
zygous NBC1 mutation in this patient.
Generation of NBC1 W516X knock-in mice
Following the electroporation of the targeting vector, the
homologous recombination with the wild-type locus was
identified by Southern blotting (Figure 2a and b). Inter-
crossing of NBC1W516X/þ mice led to the birth of NBC1þ /þ ,
NBC1W516X/þ , and NBC1W516X/W516X offspring at expected
Mendelian frequency (a total of 462 mice at day 10, 114
(24.6%) NBC1þ /þ mice, 223 (48.2%) NBC1W516X/þ mice,
and 125 (27.2%) NBC1W516X/W516X mice) confirmed by PCR
and direct sequence (Figure 2c and d). These results
suggested that the NBC1 W516X mutation did not seriously
affect embryogenesis.
Expression of NBC1 in the proximal tubule
The W516X nonsense mutations are expected to affect the
transcripts for the genes encoding NBC1. Reverse transcriptase
PCR (RT-PCR) and real-time PCR analysis demonstrated a
significant reduction of Slc4a4 transcripts in the kidney of
NBC1W516X/þ and NBC1W516X/W516X compared with NBC1þ /þ
mice (Figure 3a). The levels of NBC1 protein expression in
three genotypic mice were in parallel to their mRNA levels
(Figure 3b). We did not find the expression of truncated and
full-length NBC1 protein detected by both NBC1 N-terminal
and C-terminal antibodies in NBC1W516X/W516X mice. These
results suggested that the process of nonsense-mediated
mRNA decay (NMD), which promotes rapid mRNA
degradation of premature termination codon (PTC), might
be involved in the deficient transcription and translation in
NBC1 W516X mice. Immunofluorescence in the kidneys
showed that NBC1 expression in the basolateral membrane of
proximal convoluted tubules was normal in NBC1þ /þ ,
decreased in NBC1W516X/þ , and absent in NBC1W516X/W516X
mice (Figure 3c).
Phenotype of NBC1 W516X knock-in mice
Growth. NBC1W516X/W516X mice were smaller and grew
more slowly than their NBC1þ /þ littermates (at day 21,
body weight, 6.8±0.8 versus 12.8±0.4 g in NBC1þ /þ mice,
n¼ 10, Po0.05) and exhibited postnatal lethality before
23 days after birth. There was no significant difference in the
survival rate and growth between NBC1W516X/þ and
NBC1þ /þ mice.
Biochemical parameters. Table 1 summarizes the conse-
quences of the congenital W516X deficiency of NBC1
analyzed in 17-day-old mice. Compared with NBC1þ /þ
and NBC1W516X/þ mice, NBC1W516X/W516X mice had a
remarkable decrease in blood pH and HCO3
 concentration,
increase in blood Cl concentration, hypercalciuria, hyperci-
traturia, and more acidic urine but no apparent diarrhea,
consistent with the presence of severe pRTA. NBC1W516X/W516X
mice also had predominantly prerenal azotemia and true
volume depletion as evidenced by a significantly higher
plasma renin activity and aldosterone concentrations.
Hypercalcemia also observed in NBC1W516X/W516X mice
may reflect the fact that their renal function was significantly
diminished to excrete the filtered calcium because metabolic
acidosis per se can cause calcium mobilization from bone.
Blood HCO3
 concentrations and pH were mildly but
significantly reduced in NBC1W516X/þ mice.
Organ abnormalities. The apparent anatomical abnormal-
ities in several organs were observed in NBC1W516X/W516X
mice. Grossly, the kidneys in NBC1W516X/W516X mice were
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Figure 2 |Generation of electrogenic Naþ /HCO3
 cotransporter
(NBC1) W516X knock-in mice. (a) Gene targeting strategy.
Structure of the endogenous locus, targeting construct and targeted
allele are shown. Numbered boxes represent exons of Slc4a4. Neo
and TK denote neomycin resistance and thymidine kinase gene,
respectively. (b) Verification of homologous recombination by
Southern blotting of BglI-digested genomic DNA derived from the
selected embryonic stem (ES) cell clones (J11 and J12) before
excising neomycin resistance cassette. The 15.2 kb band is from the
wild-type allele, and 9.8 kb band from the mutated (flox) allele.
C: control genomic DNA from wild-type ES cells. (c) PCR analysis of
tail DNA for the Slc4a4 gene in NBC1þ /þ , NBC1W516X/þ , and
NBC1W516X/W516X mice. The presence of a 130-bp fragment, a 219-bp
fragment containing the remaining loxP sit, or both fragments
identifies mice with NBC1þ /þ , NBC1W516X/W516X, and NBC1W516X/þ
genotypes, respectively. (d) Direct sequencing of the PCR product
covering the mutation site in exon 11 from three mice genotypes.
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significantly smaller than those in NBC1þ /þ mice
(0.04±0.004 versus 0.07±0.003 g in NBC1þ /þ mice;
n¼ 10, Po0.05). Ocular findings in NBC1W516X/W516X mice
essentially normal in appearance before day 18 became
abnormal with cloudy cornea after their survival was
prolonged for 428 days with alkali therapy (see below), as
shown in Figure 4a. Histological analysis revealed that the
corneal opacities were because of edematous changes in
cornea (Figure 4b), not observed in NBC1þ /þ or
NBC1W516X/þ mice. These results indicate that NBC1 is
indispensable for the maintenance of corneal transparency
and hydration. Small gastrocnemius muscle mass (0.11±0.04
versus 0.32±0.04 g in NBC1þ /þ mice, n¼ 10, Po0.05) and
shrunken and impacted intestine were found in NBC1W516X/
W516X mice, as reported in NBC1-null mice.19
Compared with NBC1þ /þ mice, NBC1W516X/W516X mice
had significantly lower hemoglobin concentration, higher
reticulocyte percentage, and remarkably enlarged spleen
(weight: 0.2±0.02 versus 0.06±0.01 g, length: 1.83±0.22
versus 1.23±0.16 cm, width: 0.68±0.13 versus 0.43±
0.08 cm, height: 0.28±0.10 versus 0.16±0.06 cm NBC1þ /þ
mice, n¼ 10, all Po0.05). These findings of the increased red
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Figure 3 | Expression of electrogenic Naþ /HCO3
 cotransporter (NBC1) in the kidneys. (a) Reverse transcriptase PCR (RT-PCR) and
real-time PCR reveal downregulation of NBC1 transcripts in NBC1W516X/þ and NBC1W516X/W516X mice, n¼ 6 per group, *Po0.05 versus
NBC1þ /þ mice, #Po0.05 versus NBC1W516X/þ mice. (b) Western blotting of total kidney extracts shows that NBC1 protein expression was
moderately decreased in NBC1W516X/þ mice and absent in NBC1W516X/W516X mice, n¼ 4 per group. *Po0.05 versus NBC1þ /þ mice, #Po0.05
versus NBC1W516X/þ mice. (c) NBC1 immunofluorescence signals are localized to the basolateral membrane of renal proximal tubules.
The intensity of the NBC1 signals was moderately decreased in NBC1W516X/þ mice and absent in NBC1W516X/W516X mice. Original
magnification  400 (upper panels) and  800 (lower panels). GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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blood cell destruction and a loss of mature red blood cells
with a compensatory erythropoiesis might be caused by
severe metabolic acidosis.19 Abdominal organs appeared
paler, probably related to anemia, poor perfusion, and
malnutrition in NBC1W516X/W516X mice.
Functional analysis of NBC1 W516X in renal proximal
tubules. To evaluate the effect of W516X mutation on the
NBC1 properties, NBC1 transporter activity in the isolated
renal proximal tubules (late proximal convoluted tubules to
early proximal straight tubules; S2 segment) was analyzed by
measuring the rates of cell pH decrease in response to reduc-
tion of bath HCO3
 concentration from 25 to 12.5mmol/l
(Figure 5a). The rates of cell pH decrease were modestly
decreased in NBC1W516X/þ mice and markedly decreased in
NBC1W516X/W516X mice at day 14±2 (Figure 5b).
We also tried to measure the rates of HCO3
 absorption
(JHCO3
) from isolated renal proximal tubules with the stop-
flow microspectrofluorometric method. However, renal
proximal tubules from NBC1W516X/W516X mice around day
14 were too thin for this type of experiments requiring
luminal perfusion. Therefore, we decided to treat
NBC1W516X/W516X mice with alkali (see below), and the data
were obtained from mice at day 28±3. JHCO3
 values were
modestly decreased in NBC1W516X/þ mice and markedly
+/+
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Figure 4 |Ocular appearance and histology. NBC1W516X/W516X
mice were treated with alkali therapy, and both NBC1þ /þ and
NaHCO3-treated NBC1
W516X/W516X mice were analyzed at day 50.
(a) Ocular appearance is shown for NBC1þ /þ (left panel) and
NaHCO3-treated NBC1
W516X/W516X (right panel) mice. Cloudy
cornea is denoted with red arrows. (b) Hematoxylin and eosin (HE)
staining shows cornea edema in NaHCO3-treated NBC1
W516X/W516X
mice (lower panel), but not in NBC1þ /þ mice (upper panel).
Original magnification  400.
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Figure 5 | Intracellular pH (pHi) and HCO3
 absorption
measurement in the renal proximal tubules. (a) pHi responses
to bath HCO3
 reduction in the isolated renal proximal tubules
from the three genotypes. Typical traces for NBC1þ /þ ,
NBC1W516X/þ , and NBC1W516X/W516X mice are shown. The rates of
pHi responses were mildly reduced in NBC1
W516X/þ mice, and
severely reduced in NBC1W516X/W516X mice. (b) Summary data for
NBC1 activity in NBC1þ /þ (n¼ 8), NBC1W516X/þ (n¼ 12), and
NBC1W516X/W516X (n¼ 7) mice renal proximal tubules. (c) JHCO3
values were obtained from NBC1þ /þ (n¼ 21), NBC1W516X/þ
(n¼ 13), and NBC1W516X/W516X (n¼ 13) mice. *Po0.01 versus
NBC1þ /þ mice, #Po0.01 versus NBC1W516X/þ mice.
Table 1 | Blood and urine biochemical data of NBC1 W516X
knock-in mice
Genotype (n) +/+ (6) W516X/+ (10) W516X/W516X (6)
Blood
Hematocrit (%) 31±1 33±3 26±1*,#
pH 7.42±0.1 7.30±0.03 6.91±0.01*,#
HCO3
 (mmol/l) 24.2±0.1 17.2±0.1* 3.9±0.1**,##
Na+ (mEq/l) 154.2±7.8 154.3±6.5 147.5±5.0
K+ (mEq/l) 4.4±0.4 4.3±0.8 4.1±0.1
Cl (mEq/l) 112.3±5.5 114.3±4.1 128.5±7.7*,#
Ca2+ (mg/dl) 10.8±0.3 10.8±0.6 12.0±0.2*,#
BUN (mg/dl) 30.1±4.0 27.3±8.0 89.2±8.0**,##
Cr (mg/dl) 0.06±0.02 0.05±0.02 0.13±0.03*,#
PRA (ng/ml/h) 9.5±3.4 15.2±5.9* 30.6±6.3**,##
Aldosterone (mg/ml) 1.4±0.2 1.2±0.3 4.4±0.7**,##
Urine
pH 7.5±0.1 6.4±0.3*,# 5.5±0.1*,#
UUN (mg/dl) 2575±203 2350±113 1395±205*,#
Cr (mg/dl) 47.2±3.5 33.0±6.6* 21.3±2.3*,#
Osmolality (mOsm/kg) 1523±121 1550±219 1060±64*,#
Na+/Cr (mEq/mg) 0.18±0.02 0.15±0.03 0.26±0.05*,#
K+/Cr (mEq/mg) 0.40±0.09 0.48±0.11 0.50±0.04
Cl/Cr (mEq/mg) 0.29±0.03 0.21±0.06 0.52±0.03*,#
Ca2+/Cr (mg/mg) 0.22±0.01 0.20±0.01 3.50±0.02**,##
Citrate/Cr (mg/mg) 0.21±0.07 0.47±0.05* 2.10±0.24**,##
Abbreviations: BUN, blood urea nitrogen; Cr, creatinine; PRA, plasma renin activity;
UUN, urine urea nitrogen. *Po0.05 and **Po0.001 versus NBC1+/+ mice, #Po0.05,
and ##Po0.001 versus NBC1W516X/+ mice.
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decreased in NBC1W516X/W516X mice (Figure 5c). These
results confirmed that NBC1 has an essential role in the
HCO3
 absorption from renal proximal tubules.
Effects of alkali therapy on NBC1W516X/W516X mice
Growth. Alkali therapy with intraperitoneal (i.p.) NaH-
CO3 administration in NBC1
W516X/W516X before weaning led
to a significant gain in body weight (Figure 6a; 8.3±0.5
versus 6.9±0.4 g in NBC1W516X/W516X mice, n¼ 10, Po0.05)
and the prolonged survival timeB4 to 5 weeks after weaning
(Figure 6b). In contrast, NBC1W516X/W516X mice treated with
NaCl administration resulted in no different change in body
weight (7±0.8 g, n¼ 10) but shortened the survival time to
18 days.
Biochemical parameters. As shown in Figure 6c, i.p.
NaHCO3 administration in NBC1
W516X/W516X mice led to a
significant increase in hematocrit and HCO3
 concentration
as well as significant decrease in plasma creatinine and blood
urea nitrogen concentration. NaCl-treated NBC1W516X/W516X
mice also showed a significant decrease in plasma creatinine
and blood urea nitrogen concentration, but they still had
lower hematocrit and severe metabolic acidosis. Compared
with NaCl-treated NBC1W516X/W516X mice, NaHCO3-treated
NBC1W516X/W516X mice had a significantly lower plasma
blood urea nitrogen level. These findings supported that
predominant prerenal azotemia in NBC1W516X/W516X mice
was related to volume depletion besides the acidosis-induced
hypercatabolism.
Renal histology and distal nephron acid-base/Naþ transpor-
ters and aquaporin 2 (AQP2) expression. Histological analysis
revealed significant tubular atrophy, flattening of epithelial
cells, and tubular dilatation in renal cortex of NBC1W516X/W516X
mice (Figure 7a). Because metabolic acidosis per se does not
cause apparent histological abnormality,20 concomitant renal
+/+
W516X/W516X
W516X/W516X
W516X/W516X
W516X/W516X
W516X/W516X
120
100
80
Su
rv
iva
l r
a
te
 (%
)
60
40
40 0.2
0.15
*
*
0.1
Cr
ea
tin
in
e 
(m
g/d
l)
0.05
0
35
30
*
*
*
**
#
##
25
20
H
ct
 (%
)
15
10
6
5
4
H
CO
3 
(m
mo
l/l)
3
2
1
0
5
0
20
0
0 10 20 30 40 50
Age (days)
60 70 80 90
+/+
W516X/W516X
NaCl
W516X/W516X
NaCl
W516X/W516X
NaCl
W516X/W516X
NaCl
W516X/W516X
NaHCO3
W516X/W516X
NaHCO3
W516X/W516X
NaHCO3
125
100
BU
N 
(m
g/d
l)
75
50
0
25
W516X/W516X
NaHCO3
W516X/W516X W516X/W516X
NaCl
W516X/W516X
NaHCO3
W516X/W516X
NaCl
W516X/W516X
NaHCO3
Figure 6 | Effects of NaHCO3 and NaCl administration in NBC1
W516X/W516X mice on survival and biochemical parameters. (a) Growth
retardation and emaciation were found in NBC1W516X/W516X and NaCl-treated NBC1W516X/W516X mice, but attenuated in NaHCO3-treated
NBC1W516X/W516X mice. (b) Survival rates of NBC1W516X/W516X mice. The percentage of survival was analyzed by the ratio of the animal
numbers at birth and plotted against age. NBC1W516X/W516X and NaCl-treated NBC1W516X/W516X mice exhibited a sharp increase in mortality
starting around 17 days, but NaHCO3-treated NBC1
W516X/W516X mice prolonged the survival time up to 81 days of age. (c) Effects of NaCl or
NaHCO3 administration on hematocrit (Hct), creatinine, HCO3
, and blood urea nitrogen (BUN) in NBC1W516X/W516X mice, n¼ 6 per group,
*Po0.05 and **Po0.001 versus NBC1W516X/W516X mice and #P o0.05 and ##Po0.001 versus NaCl-treated NBC1W516X/W516X mice.
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failure found in NBC1W516X/W516X mice may account for
these histological changes and thus dysregulate the expression
of tubular acid-base/Naþ transporters and AQP2 channel.
Both NaCl-treated and NaHCO3-treated NBC1
W516X/W516X
mice exhibited the significantly attenuated changes in
histology. We also examined the expression of distal nephron
acid-base transporters in NBC1W516X/W516X mice. Unexpect-
edly, relative transcripts levels of anion exchanger 1 and V0A4
Hþ -ATPase were significantly lower in NBC1W516X/W516X
than NBC1þ /þ mice. When renal function was improved
with volume repletion, both NaCl-treated and NaHCO3-
treated NBC1W516X/W516X mice showed a significant increase
in the transcript levels of anion exchanger 1 and V0A4 Hþ -
ATPase (Figure 7b), also suggesting that impaired distal
acidification in the presence of metabolic acidosis was
secondary to the effect of renal failure.
Metabolic acidosis can upregulate the expression of AQP2
in the collecting duct and increase urine osmolality via a
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Figure 7 | Effects of alkali therapy on renal histology, distal acid-base/Naþ transporters, and aquaporin 2 (AQP2) expression.
(a) Photomicrographs of representative paraffin kidney sections from NBC1þ /þ (A, E), NBC1W516X/W516X (B, F), NaCl-treated NBC1W516X/W516X
(C, G), and NaHCO3-treated NBC1
W516X/W516X (D, H) mice stained with hematoxylin and eosin. Dilated tubules were observed in
NBC1W516X/W516X mice but attenuated in NaCl-treated and NaHCO3-treated NBC1
W516X/W516X mice. Original magnification  100 (upper
panels) and  400 (lower panels). (b) The expression in the distal tubular acidification. Real-time PCR quantification demonstrated that
transcripts levels of anion exchanger 1 (AE1) and V0A4 Hþ -ATPase were decreased in NBC1W516X/W516X mice but significantly restored by
NaCl and NaHCO3 administration. (c) Na
þ transporters and AQP2 expression. Real-time PCR reveals downregulation of Na-K-Cl
cotransporter 2 (NKCC2), epithelial sodium channel (ENaC), and upregulation of AQP2 transcripts in NBC1W516X/W516X mice. Downregulation
of NKCC2 and ENaC was corrected by volume repletion, whereas upregulation of AQP2 was further enhanced by alkali therapy; n¼ 6 per
group. *Po0.05 versus NBC1þ /þ mice, #Po0.05 versus NBC1W516X/W516X mice.
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concomitant increase in the circulating antidiuretic hormone
concentration.21 However, the decreased urine osmolality
and high urine Naþ excretion observed in NBC1W516X/W516X
mice represented the salt-losing tubulopathy. Despite the
increased expression of AQP2 mRNA, we found reduced
expression of Na-K-Cl cotransporter 2 (NKCC2) mRNA in
NBC1W516X/W516X mice, supporting the presence of salt-
losing nephropathy (Figure 7c). NaCl-treated and NaHCO3-
treated NBC1W516X/W516X mice with improved renal function
showed a significant increase in NKCC2 mRNA, also
supporting that downregulation of NKCC2 was affected by
renal failure. Similar to NKCC2, a-epithelial sodium channel
(ENaC) and gENaC mRNA expression was also diminished
in NBC1W516X/W516X mice. Their mRNA expression tended to
be increased with NaCl treatment and significantly enhanced
with NaHCO3 treatment. However, Na-Cl cotransporter and
bENaC mRNA expressions were still unchanged. Why an
upregulation of AQP2 was further enhanced by NaHCO3 but
not NaCl therapy in NBC1W516X/W516X mice remained
unclear.
Attenuated bone, spleen, and muscle abnormalities.
NBC1W516X/W516X mice had severe bone dysplasia such as
the reduction in bone length, ratio of cortical to total cross-
sectional area, and cortical width at femur, and the thickening
of growth plate. These bony changes were signi-
ficantly attenuated in NaHCO3-treated NBC1
W516X/W516X
mice (weight: 0.10±0.03 versus 0.06±0.02 versus 0.08±
0.01 g, length: 2.6±0.16 versus 1.90±0.10 versus 2.25±
0.06 cm, width: 0.28±0.03 versus 0.1±0.03 versus
0.19±0.02 cm, circumference: 1.23±0.15 versus 0.95±0.22
versus 1.15±0.13 cm in NBC1þ /þ , NBC1W516X/W516X, and
NaHCO3-treated NBC1
W516X/W516X mice, respectively,
n¼ 10, all Po0.05; Figure 8a). Consistent with previous
reports,22,23 alkali therapy for metabolic acidosis could
improve abnormal bone cell function and increase bone
mineral density.
With alkali therapy, spleen size became significantly
smaller (weight: 0.06±0.02 versus 0.24±0.05 versus 0.13±
0.04 g, length: 1.23±0.16 versus 1.83±0.22 versus 1.48±
0.31 cm, width: 0.43±0.08 versus 0.68±0.13 versus
0.49±0.12 cm, thickness: 0.16±0.06 versus 0.28±0.10
versus 0.20±0.03 cm in NBC1þ /þ , NBC1W516X/W516X,
NaHCO3-treated NBC1
W516X/W516X mice, respectively,
n¼ 10, all Po0.05). The blood reticulocytosis and anemia
were also significantly attenuated (Figure 8b). A markedly
small gastrocnemius muscle mass in NBC1W516X/W516X mice
raised a possibility that ATP-dependent ubiquitin proteasome
pathway might be involved in muscle degradation under
metabolic acidosis.24,25 Consistent with this view, trans-
cript abundance of atrogin-1/MAFbx (muscle atrophy
F-box), an E3 ubiquitin ligase, was remarkably increased in
NBC1W516X/W516X mice and significantly decreased with
NaHCO3 therapy (Figure 8c). The gastrocnemius muscle
mass (0.17±0.02 g) in NaHCO3-treated NBC1
W516X/W516X
mice were also significantly increased, compared with
NBC1W516X/W516X mice.
DISCUSSION
We created NBC1 W516X nonsense knock-in mice by
introducing a PTC into exon 11 of the SLC4A4 gene to
model our patient with isolated pRTA caused by the NBC1
W516X mutation. The growth retardation, severe pRTA, and
ocular abnormalities in NBC1W516X/W516X mice largely
recapitulated the phenotypes of our patient. NBC1 has been
thought to mediate a majority of HCO3
 uptake from renal
proximal tubules. The severe reduction of JHCO3
 in
NBC1W516X/W516X mice directly confirmed the essential role
of NBC1 in renal proximal HCO3
 absorption. This is in
contrast to the very mild acidemia observed in mice deficient
for the apical Naþ /Hþ exchanger NHE3.26 Probably, the
lack of NHE3 can be compensated at least partially by other
apical transporters including NHE8.27 Our study indicates
that the lack of NBC1 cannot be compensated by other
basolateral transporters such as Naþ -dependent and Naþ -
independent Cl/HCO3
 exchangers.28 Similarly, as in NBC1-
null mice,19 NBC1W516X/W516X mice did not show apparent
ocular abnormalities until day 18. After the prolonged
survival with alkali therapy, however, they showed the
corneal opacities because of the corneal edema. This is
consistent with the essential role of NBC1 in maintaining the
corneal hydration and transparency.11,12 The reason why
NBC1W516X/W516X mice did not develop the full brown ocular
abnormalities, such as band keratopathy, cataract, and
glaucoma typically observed in human pRTA patients with
homozygous NBC1 mutations, remains unclear. The species
differences or the relatively short life of NBC1W516X/W516X
mice even with alkali therapy may be involved.
W516X in NBC1 is a nonsense mutation. Eukaryotic cells
have at least two mechanisms that defend against the
undesired consequences potentially elicited by mRNA with
PTC. One is the elimination of PTC-containing mRNAs
through NMD surveillance mechanisms and the other is
degradation of truncated proteins after translation of the
PTC-containing mRNAs. In this in vivo study, both
expression of NBC1 mRNA and full-length protein in
NBC1W516X/þ mice were nearly half that of NBC1þ /þ
littermates, suggesting that NBC1 W516X mutant transcripts
were rapidly degraded and not translated. Furthermore,
NBC1W516X/W516X mice exhibited a minimal amount of PTC-
containing NBC1 mRNA transcripts with undetectable full-
length or truncated NBC1 W516X protein, supporting the
notion that NMD was involved in preventing translation.
The degree of metabolic acidosis in NBC1W516X/W516X
mice was more severe than that in patients with isolated
pRTA. The reasons for this discrepancy remain unclear.
Metabolic acidosis can induce the distal tubular acidification
to regenerate HCO3
 but does not cause apparent histological
abnormality.20 The lack of compensatory distal tubular
acidification and the presence of histological abnormalities
in NBC1W516X/W516X mice may definitely aggravate the degree
of metabolic acidosis. The severe loss of NBC1 function in
NBC1W516X/W516X mice caused the reduced proximal Naþ
reabsorption in addition to HCO3
 loss accompanied by Naþ
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loss in urine in combination with a poor Naþ intake, leading
to volume depletion with secondary increase in plasma renin
activity and aldosterone concentration. Severe volume
depletion in turn led to the reduced renal perfusion and
may cause the loss of viable kidney function and mass. Based
on the significant increase in the expression of anion
exchanger 1 and V0A4 Hþ -ATPase, as well as the ameliora-
tion in histological abnormalities following the improved
renal function in salt-repleted NBC1W516X/W516X mice,
renal failure related to volume depletion found in
NBC1W516X/W516X mice may account for these histological
changes and thus compromise the expression of distal acid-
base transporters. Nevertheless, the immaturity of the
neonatal kidney may also contribute to the more severe
acidosis seen in NBC1W516X/W516X mice because human
kidneys are more mature at birth than murine kidneys.29
Mild pRTA was observed in NBC1W516X/þ mice but not in
human subjects with heterozygous NBC1 mutations. We
therefore cannot exclude a possibility that the compensatory
capacity of distal tubular acidification may be fundamentally
less in mice than in humans.
Metabolic acidosis as a consequence of defective NBC1
may adversely affect the function of multiple organ tissues
and negatively impact a variety of metabolic processes.30,31 It
is well known that metabolic acidosis can cause detrimental
systemic effects such as cardiovascular, pulmonary, gastro-
intestinal, skeletal, hematological, and hormone abnormal-
ities, independently leading to morbidity and mortality.32–37
Growth retardation from metabolic acidosis has also been
seen in studies of infants and children with RTA.38 The
NBC1W516X/W516X mice exhibited several typical features
caused by metabolic acidosis. They were smaller at birth, had
growth failure, anemia, splenomegaly, short bone length with
thin cortical area, hypercalciuria, and poor perfusion of
organs. A striking increase in E3 ubiquitin ligase (atrogin-1/
MAFbx), an index of ubiquitin proteasome pathway-
mediated muscle protein degradation, in NBC1W516X/W516X
mice indicated the presence of severe protein catabo-
lism.25,39,40 It is noteworthy that these mice died before
weaning, unless they were treated with alkali.
Although the reduced renal function related to volume
depletion may affect the life expectancy in NBC1W516X/W516X
mice, we considered that severe metabolic acidosis was the
primary culprit behind early lethality and the organ
abnormalities in NBC1W516X/W516X mice. This was supported
by the findings that NaHCO3, but not NaCl, administration
not only prolonged survival time after weaning, but also
helped increase growth rate, attenuate protein hypercatabo-
lism, reduce splenomegaly and anemia, improve bone
growth, and decrease other organ abnormalities. Our
findings are consistent with the beneficial effects of alkali
therapy on the prevention of growth retardation, malnutri-
tion, osteomalacia, and even death in children with RTA.38,41
Alkali therapy in NBC1W516X/W516X mice was also found to
attenuate the renal histological changes and enhance the
expression of some tubular acid-base transporters. A recent
study also showed that HCO3
 supplementation slowed the
progression of renal failure and improved nutrition status in
chronic kidney disease patients.42 Taken together,
NBC1W516X/W516X mice may be used as an animal model to
evaluate the deleterious effects of metabolic acidosis and
investigate the mechanisms underlying the effect of metabolic
acidosis on cell and organ dysfunction.
Mutation-specific approaches according to the different
classes of genetic mutations are currently being investigated as
new therapies in genetic disorders. In particular, PTC124, a
novel and potent nonsense suppression agent with less toxicity
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Figure 8 |Alkali administration attenuated bone, spleen, and
muscle abnormalities. (a) Bone tomography and histology are
shown from NBC1þ /þ (upper panel), NBC1W516X/W516X (middle
panel), and NaHCO3-treated NBC1
W516X/W516X (lower panel) mice.
NBC1W516X/W516X mice exhibited radiographic thin cortical bone
(red arrows) and histological widening of the growth plate (black
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administration. (b) Representative images of spleen and
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W516X/W516X mice. NBC1W516X/W516X mice
showed splenomegaly and high percentage of nucleated red
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Gastrocnemius muscle image and relative transcripts levels of
atrogin-1/muscle atrophy F-box (MAFbx) in the muscle. Real-time
PCR demonstrated that the markedly increased expression of
atrogin-1/MAFbx found in NBC1W516X/W516X mice was significantly
attenuated with NaHCO3 therapy, n¼ 6 per group. *Po0.05 and
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than conventional aminoglycosides, has been developed for the
treatment of genetic disorders caused by nonsense muta-
tions.43,44 These W516X nonsense knock-in mice may also
represent a favorable model to test the efficacy of PTC124 and
other therapeutic agents such as NMD inhibitors.
In conclusion, NMD was involved in the defective
transcription and translation of the nonsense W516X
mutation, leading to remarkably reduced NBC1 activity in
the isolated renal proximal tubules of NBC1W516X/W516X
mice. Because these NBC1W516X/W516X mice feature isolated
pRTA and severe metabolic acidosis, NBC1 is evidently
crucial for maintaining systemic acid-base homeostasis.
Severe metabolic acidosis related consequent to defective
NBC1 contributes to early lethality, as NaHCO3, but not
NaCl, administration results in significant increase in survival
time, decrease in protein catabolism, and attenuation in
other related organ abnormalities. These mice may represent
an ideal model for metabolic acidosis and in vivo platform for
mutation-specific rescue therapy in the future.
MATERIALS AND METHODS
Genetic analysis for SLC4A4 gene
The genetic study was approved by the ethics committee on human
studies at Tri-Service General Hospital, National Defense Medical
Center, in Taiwan, ROC. The subjects were given a detailed description
of the study. Genomic DNAs were isolated and purified from
peripheral blood of the patient, family members, and 100 normal
control subjects. The 23 exons of the complete coding region of the
SLC4A4 gene (NCBI (National Center for Biotechnology Informa-
tion): NP 003750, GI: 4507025) were examined using Taq polymerases
DNA-sequencing method in Perkin Elmer 2400 (Perkin Elmer Japan
Applied Biosystems Division, Tokyo, Japan) and ABI 3130 automated
DNA Sequencer (Applied Biosystems, Foster City, CA).
Generation of NBC1 W516X knock-in mice
All the animal studies were performed according to the National
Institutes of Health guidelines for the use and care of experimental
animals. To generate NBC1 W516X knock-in mice, the targeting
vector was prepared by the gap-repair technique.16 Briefly, mouse
Slc4a4 genomic DNA encoding NBC1 was isolated from a 129X1/SvJ
genomic DNA BAC library. The nonsense mutation NBC1 W516X
(TGG to TGA) was introduced by PCR using the forward primer:
50-GGATTGGCCTGTGATCAGCCTTCATGTG-30 and reverse pri-
mer: 50-CACATGAAGGCTGATCACAG GCCAATCC-30. The entire
sequence was verified by sequencing. We used homology recombi-
nation in embryonic stem cells derived from 129X1/SvJ 129S1 to
create a mutant allele in which exon 11 of the NBC1 gene was
replaced by a cassette expressing the selective marker neomycin
resistance gene followed by the mutant exon 11 (W516X). After
selection with 240 mg/ml G418 and 2 mM gancyclovir, embryonic
stem cell clones targeted was confirmed by Southern blotting of cell
DNA digested with BglI, and hybridized to a probe. The neo cassette
was excised by transfecting the Cre-expression plasmid into the
targeted NBC1flox/þ embryonic stem cells. The NBC1W516X/þ
embryonic stem cells were selected by PCR (forward primer:
50-GGAGAGCTTCCACTCAGAAG-30 and reverse primer: 50-AGCT
TCCTCCACAGAGCATC-30), confirmed by Southern blotting, and
then injected into C57BL/6 blastocysts. Chimeric males were bred
with C57BL/6 females to produce NBC1W516X/þ mice. NBC1W516X/þ
mice (F1) were mated with each other to produce NBC1þ /þ ,
NBC1W516X/þ , and NBC1W516X/W516X littermates (F2), in which tail
genomic DNAs were applied for genotyping by PCR with forward
primer 50-GGAGAGCTTCCACCTCAGAAG-30, and reverse primer
50-CCAGAAAATTTTAAGGATTTGGTT-30.
RNA isolation, RT-PCR, and real-time RT-PCR
Total RNA was extracted using Trizol Reagent (Invitrogen,
Groningen, The Netherlands) according to the manufacturer’s
protocol. RT-PCR products were separated in 2% agarose and
visualized by ethidium bromide. The Applied Biosystems 7500 Real-
Time PCR System and the fluorescent dye SYBR Green (Applied
Biosystems, Melbourne, VIC, Australia) were used for real-time
quantitative RT-PCR analysis. The amplification reactions were
performed using GAPDH (glyceraldehyde-3-phosphate dehydro-
genase) as an endogenous control. Results were expressed using the
comparative Ct method. The DCt values were calculated in every
sample for each gene of interest as Ctgene of interest–CtGAPDH and
relative changes in the expression level was performed by
subtraction of DCt from NBC1þ /þ mice to the corresponding
Ct from the NBC1W516X/W516X, NaHCO3-treated, and NaCl-treated
NBC1W516X/W516X mice. Sequences of primers used for real-time
quantitative RT-PCR are listed in Table 2.
Western blotting and immunofluorescence staining
The western blotting and immunofluorescence stain were carried
out as described.45 The relative expression levels of NBC1 were
examined by antibodies recognized with N-terminal (AB3212) or
C-terminal (AB3204) of NBC1 (Chemicon, Temecula, CA).46
Measurements of NBC1 activity in isolated renal proximal
tubules
The proximal tubule (S2 segment) fragment was microdissected
manually and transferred to a perfusion chamber mounted on an
inverted microscopy, and both ends of tubule were sucked into two
holding pipettes. The tubule was incubated with acetoxymethylester
form of a pH-sensitive fluorescence dye 20,70-bis(carboxyethyl)-
5(6)-carboxyfluorescein (BCECF; Dojindo, Kumamoto, Japan), and
intracellular pH was monitored with a photometry system (OSP-10;
Olympus, Tokyo, Japan). Prewarmed (38 1C) Dulbecco’s modified
Eagle’s tissue culture medium (Gibco, Dreieich, Germany), equili-
brated with 5% CO2/95% O2 gas, was used for the peritubular
perfusate, which was shown to be essential for the long-term
functional preservation of isolated proximal tubules.47 Bath HCO3

concentrations were reduced from 25 to 12.5mmol/l, and the rates
of intracellular pH decrease to bath HCO3
 reduction were used to
estimate the NBC1 activity as described.47,48
Measurements of JHCO3

The tubular lumen was perfused with Ringer solution, which
contained 25mmol/l HCO3
, 40mmol/l raffinose, and BCECF,
whereas Dulbecco’s modified Eagle’s medium was used for bath
perfusate. Luminal pH (pHL) was monitored on the OSP-10 system.
To determine JHCO3
, the rapid (B80 nl/min) luminal perfusion
was abruptly stopped by suddenly reducing the perfusion pressure
from B18 to 0 cmH2O. After stop flow, pHL fell from 7.4 to values
near 6.8 within 30 s, where it remained virtually constant. This
decrease in pHL reflects the gradual absorption of HCO3
. The decay
in luminal HCO3
 concentration ([HCO3
]L) was calculated
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from the changes in pHL, and JHCO3
 was calculated from the
following equation:
JHCO3 ¼ p  r2ð½HCO3 0  ½HCO3 1Þk
Where r is the luminal radius before stop flow, [HCO3
]0 and
[HCO3
] are [HCO3
]L before stop flow and in the steady state,
respectively, and k is the rate constant of [HCO3
]L decline.
Phenotype analysis
Blood and urine measurements. Mouse plasma electrolytes
were measured using a blood gas analyzer (ABL505; Radiometer,
Copenhagen, Denmark) for determination of pH, calculated HCO3
.
Urine samples were collected from the urinary bladder. The pH was
measured immediately after collecting urine using a pH micro-
electrode (PHR146; Lazar, Los Angeles, CA). Urine creatinine,
plasma and urine urea nitrogen, electrolytes, and osmolality were
determined using automated methods (AU 5000 chemistry analyzer;
Olympus). Plasma creatinine concentration was determined by
high-performance liquid chromatography assay as previously
described.49 Plasma renin activity was measured by radioimmu-
noassay using a kit (Diagnostic Product, Llamberis, UK). Plasma
aldosterone concentration was measured by the two-antibody
radioimmunoassay method with a SPAC-S aldosterone kit (Daiichi
Radioisotope Institute, Tokyo, Japan). Urinary citrate concentration
was measured by R-Biopharm kit (Murten, Switzerland). Blood
smears were collected into tubes containing EDTA and then stained
with Giemsa stain for measuring the percentage of cell counts.
Organs assessment. For histological analysis, renal, ocular,
and bone tissues were fixed in 10% formalin, and then bone tissues
were decalcified in OSTEOMOLL (Merck, KGaA, Darmstadt,
Germany). The tissues were embedded in paraffin. For radiographic
analysis, the mice were scanned with high-resolution mCT40 (Scanco
Medical, Basserdorf, Switzerland) in a sample holder with energy
level of 55 kV and intensity of 145 mA. The three-dimensional
morphometric analysis was conducted with the built-in software of
the mCT system.
Correction of metabolic acidosis. For the alkali therapy, i.p.
administration of 7.5% NaHCO3 15 ml/g body weight once a day
began from day 10 after birth of NBC1W516X/W516X mice. Once
NBC1W516X/W516X mice survived after weaning, i.p. administration
was discontinued, followed by free access to 280mmol/l NaHCO3 in
the drinking solution. The i.p. administration of 7.5% NaCl
equivalent to the dose of NaHCO3 as a treatment control was
employed in another group of NBC1W516X/W516X mice.
Statistical analysis
All results are expressed as mean±s.d., except the mRNA expression
values, NBC1 activity, and JHCO3
 values as the mean±s.e.m.
One-way analysis of covariance was used to compare the differ-
ence among three groups (NBC1þ /þ , NBC1W516X/þ , and
NBC1W516X/W516X mice). An unpaired Student’s t-test was per-
formed in NBC1W516X/W516X mice treated with NaCl or NaHCO3
administration. The Mann–Whitney U-test was used when the
variables between two groups were not normally distributed.
The survival data were analyzed by Fisher’s exact probability test.
The P-values ofo0.05 were considered to be statistically significant.
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